SCHEMBL13219212

SCHEMBL13219212

COc1cnc2c(c1)c(CCC(=O)O)nn2S(=O)(=O)c1ccc(Oc2ccncc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.43
▸ PPARA Q07869 3/20 0.43
▸ PPARD Q03181 2/20 0.43
▸ MAPT P10636 5/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ PTGDR2 Q9Y5Y4 4/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MMP1 P03956 2/20 0.36
▸ POLB P06746 2/20 0.36
▸ HTT P42858 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3034325 0.92 PPARG (0.51) PPARGPPARAPPARDMAPTPTGDR2
SCHEMBL13219211 0.91 TBXAS1 (0.42) PPARGPPARAPPARDMAPTPTGDR2
SCHEMBL13219232 0.85 ADAMTS4 (0.47) PPARGPPARAPPARDPTGDR2KMT2A
SCHEMBL13219219 0.85 PPARG (0.40) PPARGPPARAPPARDMAPTKDM4E
SCHEMBL13219234 0.83 FFAR1 (0.46) PPARGPPARAPPARDMAPTKMT2A
SCHEMBL13219213 0.82 RXRA (0.42) PPARGPPARAPPARDKDM4EPTGDR2
SCHEMBL13219235 0.82 FFAR1 (0.44) PPARGPPARAPPARDMAPTKMT2A
SCHEMBL13219227 0.79 LMNA (0.42) PPARGPPARAPPARDPTGDR2LMNA
SCHEMBL13219225 0.78 MAPT (0.41) PPARGPPARAPPARDMAPTHTT
SCHEMBL3030572 0.76 PPARG (0.62) PPARGPPARAPPARDMAPTPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PPARG, PPARD, PPARA PPARG 1/4885PPARA 3/4885PPARD 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback